Mirjam A. Riedinger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mirjam A. Riedinger has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
M. de Leeuw
Department of Psychiatry Leiden University Medical Centre Leiden The Netherlands
3 shared publicationsE.J. Giltay
2 shared publications- Erik J. Giltay
Department of Psychiatry Leiden University Medical Center Leiden The Netherlands
2 shared publications N.J.A. van der Wee
2 shared publicationsB. W. J. H. Penninx
Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam the Netherlands
1 shared publicationE. El Filali
Department of Mood disorders, PsyQ, Parnassia Group, The Hague, the Netherlands
1 shared publication
Latest Publications
- Open Access
- 22 September 2026
- Published by Elsevier in The European Journal of Psychiatry
- Vol. 40 (4)
Cluster headache and bipolar disorders: Phenotypical overlap and comorbidity
- 22 September 2026
- Published by Elsevier in The European Journal of Psychiatry
- Vol. 40 (4)
Open AccessCluster headache and bipolar disorders: Phenotypical overlap and comorbidity
- Open Access
- 17 March 2026
- Published by Wiley in Bipolar Disorders
- Vol. 28 (3) , e70104
Dietary Quality in Bipolar Disorder Compared to Unipolar Depression (Current and Remitted) and Healthy Controls: The Netherlands Study of Depression and Anxiety
Background: Patients with bipolar disorder (BD) have an increased risk to develop cardiovascular disease. Western diets have been hypothesized to increase the risk of cardiovascular disease in BD, but dietary habits in BD have not been extensively studied. We therefore assessed in a large cohort dietary quality in BD patients, in patients with current and remitted unipolar depression (UD), and healthy controls (HC). Methods: In total 1358 participants were included from the Netherlands Study of Depression and Anxiety (NESDA) and categorized into four groups: BD ( n = 100, 48.0% male, mean age 50.9), current UD ( n = 199, 28.0% male, mean age 52.4), remitted UD ( n = 722, 29.8% male, mean age 52.4), and HC ( n = 337, 40.7% male, mean age 51.2). Diet was assessed through the 238‐item Food Frequency Questionnaire (FFQ), which yielded the ‘Mediterranean Diet Score’ (MDS). Dietary scores were compared using multivariate regression analyzes adjusting for sociodemographics, physical activity, and smoking. Results: BD patients scored significantly lower on the MDS than those with remitted UD ( p = 0.01) and healthy controls ( p = 0.02) but did not differ from those with current UD. Effect sizes were 0.24 for BD vs. remitted UD and 0.25 for BD vs. HC. Furthermore, BD patients had on average a higher waist circumference ( p = 0.03) and BMI ( p = 0.02) than healthy controls. Conclusion: The average dietary quality of BD patients was of lesser quality compared to that in patients with remitted UD and HC. This may have contributed to the increased waist circumference and higher BMI we found among BD patients, with its adverse health consequences.
- 17 March 2026
- Published by Wiley in Bipolar Disorders
- Vol. 28 (3) , e70104
Open AccessDietary Quality in Bipolar Disorder Compared to Unipolar Depression (Current and Remitted) and Healthy Controls: The Netherlands Study of Depression and Anxiety
Background: Patients with bipolar disorder (BD) have an increased risk to develop cardiovascular disease. Western diets have been hypothesized to increase the risk of cardiovascular disease in BD, but dietary habits in BD have not been extensively studied. We therefore assessed in a large cohort dietary quality in BD patients, in patients with current and remitted unipolar depression (UD), and healthy controls (HC). Methods: In total 1358 participants were included from the Netherlands Study of Depression and Anxiety (NESDA) and categorized into four groups: BD ( n = 100, 48.0% male, mean age 50.9), current UD ( n = 199, 28.0% male, mean age 52.4), remitted UD ( n = 722, 29.8% male, mean age 52.4), and HC ( n = 337, 40.7% male, mean age 51.2). Diet was assessed through the 238‐item Food Frequency Questionnaire (FFQ), which yielded the ‘Mediterranean Diet Score’ (MDS). Dietary scores were compared using multivariate regression analyzes adjusting for sociodemographics, physical activity, and smoking. Results: BD patients scored significantly lower on the MDS than those with remitted UD ( p = 0.01) and healthy controls ( p = 0.02) but did not differ from those with current UD. Effect sizes were 0.24 for BD vs. remitted UD and 0.25 for BD vs. HC. Furthermore, BD patients had on average a higher waist circumference ( p = 0.03) and BMI ( p = 0.02) than healthy controls. Conclusion: The average dietary quality of BD patients was of lesser quality compared to that in patients with remitted UD and HC. This may have contributed to the increased waist circumference and higher BMI we found among BD patients, with its adverse health consequences.
- Open Access
- 24 January 2025
- Published by Elsevier in The European Journal of Psychiatry
- Vol. 39 (3)
Effectiveness of bright light therapy in patients suffering from unipolar or bipolar depression; A naturalistic study
- 24 January 2025
- Published by Elsevier in The European Journal of Psychiatry
- Vol. 39 (3)
Open AccessEffectiveness of bright light therapy in patients suffering from unipolar or bipolar depression; A naturalistic study
- Open Access
- 24 March 2024
- Published by Elsevier in Journal of Affective Disorders
- Vol. 355, 157-166
A healthy dietary pattern is associated with microbiota diversity in recently diagnosed bipolar patients: The Bipolar Netherlands Cohort (BINCO) study
- 24 March 2024
- Published by Elsevier in Journal of Affective Disorders
- Vol. 355, 157-166
Open AccessA healthy dietary pattern is associated with microbiota diversity in recently diagnosed bipolar patients: The Bipolar Netherlands Cohort (BINCO) study
- Open Access
- 1 September 2023
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 38 (5) , e2881
Lithium in bipolar depression: A review of the evidence
Background: Lithium is widely used as treatment of acute mania and as prophylactic therapy for bipolar disorder. International and national guidelines also consider lithium as a possible treatment of acute bipolar depression. Research on the use of lithium in bipolar depression, however, seems to be limited compared to the data available for its efficacy in the other phases of bipolar disorder.Objective: To provide a systematic review of the evidence for lithium in the treatment of acute bipolar depression and provide directions for further research.Method: A systematic review of clinical studies investigating the use of lithium in bipolar depression was performed using preferred reporting items for systematic reviews and meta‐analyses guidelines in Pubmed, Embase and Psychinfo using the medical subjects headings and free text terms “lithium,” “bipolar depression,” “dosage,” “serum concentration” and “bipolar disorders.”Results: This review included 15 studies with a total of 1222 patients, between the age of 18 and 65, suffering from bipolar depression of which 464 were treated with lithium. There are currently only limited and low‐quality data on the efficacy of lithium as a treatment of bipolar depression. It appears that there have been no placebo controlled randomized controlled trials with lithium concentrations that are considered to be therapeutic. The older studies suffered from limitations such as small sample sizes, insufficient treatment lengths, and insufficient monitoring of serum concentrations.Conclusion: In contrast to data for the treatment of mania and prophylaxis, robust data on the efficacy of lithium in bipolar depression is currently lacking, making it impossible to make conclusions regarding efficacy or inefficacy, for which further research is needed.
- 1 September 2023
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 38 (5) , e2881
Open AccessLithium in bipolar depression: A review of the evidence
Background: Lithium is widely used as treatment of acute mania and as prophylactic therapy for bipolar disorder. International and national guidelines also consider lithium as a possible treatment of acute bipolar depression. Research on the use of lithium in bipolar depression, however, seems to be limited compared to the data available for its efficacy in the other phases of bipolar disorder.Objective: To provide a systematic review of the evidence for lithium in the treatment of acute bipolar depression and provide directions for further research.Method: A systematic review of clinical studies investigating the use of lithium in bipolar depression was performed using preferred reporting items for systematic reviews and meta‐analyses guidelines in Pubmed, Embase and Psychinfo using the medical subjects headings and free text terms “lithium,” “bipolar depression,” “dosage,” “serum concentration” and “bipolar disorders.”Results: This review included 15 studies with a total of 1222 patients, between the age of 18 and 65, suffering from bipolar depression of which 464 were treated with lithium. There are currently only limited and low‐quality data on the efficacy of lithium as a treatment of bipolar depression. It appears that there have been no placebo controlled randomized controlled trials with lithium concentrations that are considered to be therapeutic. The older studies suffered from limitations such as small sample sizes, insufficient treatment lengths, and insufficient monitoring of serum concentrations.Conclusion: In contrast to data for the treatment of mania and prophylaxis, robust data on the efficacy of lithium in bipolar depression is currently lacking, making it impossible to make conclusions regarding efficacy or inefficacy, for which further research is needed.